Drugs / ribose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00004658 | Mar 1995 → ? | 5-nucleotidase syndrome | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ribose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004658 ↗ |
| Route | Oral | “oral ribose” NCT00004658 ↗ |